Related Experiment Video
Updated: Jun 7, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
BRAF inactivation drives aneuploidy by deregulating CRAF
Tamihiro Kamata1, Jahan Hussain, Susan Giblett
1Department of Biochemistry, University of Leicester, Leicester, United Kingdom.
Mutant BRAF Aspartate-594, though kinase inactive, promotes cancer by inducing aneuploidy (abnormal chromosome number) via Craf activation. This finding links Craf to chromosomal instability, impacting cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aspartate-594 is a common BRAF mutation in human cancers, but its role is unclear as mutants are kinase inactive.
- Understanding how kinase-inactive BRAF mutants contribute to cancer is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the mechanism by which the BRAF Aspartate-594 mutant (D594A) contributes to cancer development.
- To determine the role of Craf and the MEK/ERK pathway in the D594A-induced phenotype.
Main Methods:
- Utilized a conditional knock-in mouse model expressing the (D594A)Braf mutant.
- Assessed aneuploidy in murine splenocytes and mouse embryonic fibroblasts.
- Investigated the involvement of Craf and the MEK/ERK pathway using specific inhibitors.
Main Results:
- The (D594A)Braf mutant did not directly drive tumor development but induced aneuploidy.
- Aneuploidy was dependent on the related gene product Craf.
- MEK inhibitor U0126 prevented the growth of aneuploid cells but not their emergence.
Conclusions:
- The BRAF D594A mutant contributes to cancer by inducing aneuploidy through Craf.
- This study reveals a novel link between Craf and chromosomal stability.
- Findings have implications for understanding cancers with BRAF mutations that hyperactivate Craf.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Nondisjunction
Anaphase Promoting Complex
Inhibition of Cdk Activity

